Performance Of Peptide Research Articles

BCL-2 double take

Researchers at the Burnham Institute and Dana-Farber have independently identified peptides that modulate BCL-2-mediated apoptosis in strikingly opposite ways. One company, Aileron, has already been formed around the Dana-Farber findings, whereas the Burnham group is considering developing D-enantiomers or mimetics to optimize its peptide's performance.